INSULET CORP

Insulet Corp (PODD) climbs 0.48% as investors eye its insulin‑infusion tech and potential upside, while peers push AI, cloud, and governance trends in healthcare.

Insulet shares climb 0.61% to $142.64, but investors remain cautious as the company’s insulin‑delivery tech faces stiff competition and needs a breakthrough catalyst to lift its $9.8 b market cap higher.